Predicting HFNC Failure in Acute Hypoxemic Respiratory Failure using Metabolomics and Clinical Data
Official title: Metabolomics and Clinical Data to Predict High-Flow Nasal Cannula Failure and Optimize Respiratory Support in Acute Hypoxemic Respiratory Failure
Run by Hospital del Mar Research Institute (IMIM) · NCT07607080 · Data updated 2026-11-12
This study tests whether metabolomic blood profiles combined with routine clinical data can predict which adults with acute hypoxemic respiratory failure on high-flow nasal cannula will fail and need escalation of care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Hospital del Mar Research Institute (IMIM) Academic / other |
| Locations | 1 site (Barcelona, Catalonia) |
| Status | Recruiting |
| Started | June 4, 2026 |
| Main results expected | May 2029 |
| Study ends | May 2029 |
| Registry record updated | June 8, 2026 |
| Trial ID | NCT07607080 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with ICU-admitted acute hypoxemic respiratory failure treated with HFNC within the first 24 hours of initiation.
✕Probably not a fit
Patients who do not have HFNC failure may not experience a direct benefit from the metabolomic approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls adults with acute hypoxemic respiratory failure who are started on HFNC in the ICU. Researchers collect clinical, physiological, and laboratory data, plus blood samples for metabolomic analysis, to identify patterns associated with HFNC failure. The aim is to build models that combine metabolomic and clinical information to predict escalation of respiratory support and important outcomes. Primary goals are to identify predictors of HFNC failure; secondary goals include associations with intubation, duration of support, ICU stay, and mortality. The study seeks to support personalized respiratory management for AHRF.
Why it matters
Potential benefit: If successful, clinicians could better anticipate HFNC failure and tailor respiratory strategies earlier to improve outcomes.
How similar studies have gone: Metabolomic approaches have shown potential in related critical care predictions, but application to HFNC failure prediction is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years old). * Admission to the intensive care unit (ICU) with acute hypoxemic respiratory failure (AHRF). * Treatment with high-flow nasal cannula (HFNC) as the initial respiratory support strategy. * Inclusion within the first 24 hours after HFNC initiation. * Provision of informed consent by the patient or legally authorized representative. Exclusion Criteria: * Age \<18 years. * Active do-not-resuscitate (DNR) orders or limitation of therapeutic effort. * Refusal or inability to provide informed consent. * Previous invasive mechanical ventilation before study inclusion.
Where it's running
-
Hospital del Mar
Barcelona, Catalonia, Spain Recruiting
Study contacts
- Principal investigator: Francisco José Parrilla-Gómez, MD, Phd — Hospital del Mar
- Study coordinator: Francisco José Parrilla-Gómez, MD, Phd
- Email: fparilla@hmar.cat
- Phone: +34 747424848
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure
This study tests whether allowing spontaneous breathing or using controlled ventilation is better for adults with acute hypoxemic respiratory failure who need invasive mechanical ventilation.
-
IL-6 guided dexamethasone or tocilizumab treatment for hospitalized acute hypoxemic respiratory failure
This study will test whether measuring IL-6 to guide early treatment with dexamethasone or tocilizumab helps adults hospitalized with new acute hypoxemic respiratory failure.
-
How changing PEEP affects breathing drive and effort during pressure‑support ventilation
We will test whether changing PEEP levels changes neural respiratory drive and inspiratory effort in adults on pressure‑support ventilation for moderate‑to‑severe ARDS or acute hypoxemic respiratory failure.
-
Intubation strategies for adults with acute hypoxemic respiratory failure
This trial will test two different rules for when to intubate adults with acute hypoxemic respiratory failure to see which approach keeps patients safer while avoiding unnecessary mechanical ventilation.
-
PEEP tuning in acute respiratory failure using CT and EIT data
Researchers will look at routine CT and electrical impedance tomography data from adults on mechanical ventilation to see how different PEEP levels relate to lung information, without any new interventions.
-
Using Electrical Impedance Tomography to Optimize Ventilator Settings in Patients with Severe Breathing Problems
This study is trying to see if using a special imaging technique can help set ventilators better for patients with severe breathing problems like acute respiratory failure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.